News

Podcast

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Author(s):

Alexandra Gerlach, Associate Editor

This segment takes a deeper dive into toxicity management—focusing not just on what to monitor, but how institutions are putting these protocols into action in real-world clinical settings.

Related Videos
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit: Peter Hansen | stock.adobe.com
Related Content
Raw vegetables with blood glucose meter, syringe, lancet and stethoscope on desk, diabetes healthy diet concept - Image credit: neirfy | stock.adobe.com
May 29th 2025

Going with the Flow: Updates in Diabetes and Chronic Kidney Disease

Sharon Zhu, PharmD, BCGP, corresponding author Veronica Sozio, PharmD, BCPS Rachel L. Quinn, PharmD, BCACP, AE-C, CDCES
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
Visualization of bispecific antibody attacking cell | Image Credit: © miss irine - stock.adobe.com
May 29th 2025

ASCO 2025: Adding Elranatamab to Daratumumab, Lenalidomide Induces Durable Responses in Newly Diagnosed Multiple Myeloma

Alexandra Gerlach, Associate Editor
Pharmacist Involvement in Clinical Research and the FINEARTS-HF Trial
May 20th 2025

Pharmacist Involvement in Clinical Research and the FINEARTS-HF Trial

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Infectious viruses such as respiratory syncytial virus (RSV) causing respiratory infections - Image credit: Artur | stock.adobe.com
May 29th 2025

Study Reveals Impact of RSV on the Heart

Kennedy Ferruggia, Assistant Editor
Abnormal myeloma cell growth in bone marrow | Image Credit: © Khella - stock.adobe.com
May 29th 2025

Daratumumab Plus VRd Yields Sustained MRD-Negativity Regardless of Cytogenetic Risk Status in NDMM

Alexandra Gerlach, Associate Editor